Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma

PURPOSE: Despite recent advances, multiple myeloma remains incurable and most patients eventually develop progressive disease. Allogeneic hematopoietic stem cell transplantation (allo HCT) offers a potentially curative option in 10–20% of patients with relapsed or refractory disease. We evaluated th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Efebera, Yvonne A., Qureshi, Sofia R., Cole, Suzanne M., Saliba, Rima, Pelosini, Matteo, Patel, Ronak M., Koca, Ebru, Mendoza, Floralyn L, Wang, Michael, Shah, Jatin, Alousi, Amin, Hosing, Chitra, Popat, Uday, Kebriaei, Partow, Anderlini, Paolo, Khouri, Issa F., Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414196/
https://ncbi.nlm.nih.gov/pubmed/20178853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.02.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados